Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats. [electronic resource]
Producer: 20190815Description: 236 p. digitalISSN:- 1471-2261
- Animals
- Atrial Fibrillation -- enzymology
- Diabetes Mellitus, Experimental -- blood
- Diabetes Mellitus, Type 2 -- blood
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Heart Atria -- drug effects
- Hypoglycemic Agents -- pharmacology
- Male
- Metformin -- pharmacology
- Phosphorylation
- Protein Kinase C -- metabolism
- Rats, Wistar
- Signal Transduction -- drug effects
- Small-Conductance Calcium-Activated Potassium Channels -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.